Advanced Enzyme Technologies Limited has informed the Exchange that Board of Directors at its meeting held on May 13, 2025, declared Interim Dividend of Rs. 4 per equity share.
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Advanced Enzyme Technologies Limited, at its meeting held on May 13, 2025, declared an Interim Dividend of Rs. 4 per equity share (200% on face value of Rs. 2) for FY 2025-26, with a record date of May 17, 2025 and payment on or before June 10, 2025. It also recommended a Final Dividend of Rs. 1.20 per share (60%) for FY 2024-25, subject to shareholder approval at the 36th AGM on July 30, 2025, with a record date of July 23, 2025 — taking total dividends for the year to Rs. 5.20 per share. The Board approved audited consolidated FY25 results showing total income of Rs. 6,699.51 million (vs Rs. 6,605.32 million in FY24) and net profit of Rs. 1,339.74 million (vs Rs. 1,369.51 million), a marginal dip of about 2% YoY. EPS stood at Rs. 11.72 (basic). Additionally, the Board approved the incorporation of a new wholly-owned subsidiary in India and appointed Mr. Shiv Hari Jalan as Secretarial Auditor for five years. Statutory auditor MSKA & Associates issued an unmodified opinion on the financials.
Shareholders get a healthy total dividend payout of Rs. 5.20 per share, with the interim dividend payable quickly by June 2025, which is supportive for income-focused investors. However, the marginal decline in net profit and broadly flat revenue growth may limit upside momentum in the stock; the new subsidiary signals management's expansion intent but adds execution risk.